Abstract
In population studies of individuals given the antihypertensive drug debrisoquine1,3, two distinct phenotypes have been described: extensive metabolizers excrete 10–200 times more of the urinary metabolite 4-hydroxydebrisoquine than poor metabolizers. In family studies the poor-metabolizer phenotype behaves as an auto-somal recessive trait with an incidence between 5% and 10% in the white population of Europe and North America1–4, and extends to the deficient metabolism of more than 20 commonly prescribed drugs1–4. Clinical studies have shown that such individuals are at high risk for the development of adverse side effects from these and probably many other drugs1–6. Here we show that poor meta-bolizers have negligible amounts of the cytochrome P450 enzyme P450dbl. We have cloned the human P450dbl complementary DNA and expressed it in mammalian cell culture. Furthermore, by directly cloning and sequencing cDNAs from several poor-metabolizer livers, we have identified three variant messenger RNAs that are products of mutant genes producing incorrectly spliced dbl pre-mRNA, providing a molecular explanation for one of man's most commonly defective genes (frequency of mutant alleles 35-43%).
Similar content being viewed by others
References
Idle, J. R. & Smith, R. L. Drug Metab. Rev. 9, 301–317 (1979).
Kupfer, A. & Preisig, R. Semin. Liver Dis. 3, 341–354 (1983).
Eichelbaum, M. Fed. Proc. 43, 2298–2302 (1984).
Price-Evans, D. A. in Ethnic Differences in Reactions to Drugs and Xenobiotics (eds Kalow, W., Goedde, H. W. & Agarwal, D. P.) 491–526 (Liss, New York, 1986).
Davies, D. S., Kahn, G. C., Murray, S., Brodie, M. J. & Boobis, A. R. Br. J. clin. Pharmacol. 11, 88–91 (1981).
Meyer, U. A., Gut, J., Kronbach, T., Skoda, C., Meier, U. T. & Catin, T. Xenobiotica 16, 449–464 (1986).
Gonzalez, F. J. et al. DNA 6, 149–161 (1987).
Kronbach, T., Mathys, D., Gut, J., Catin, T. & Meyer, U. A. Analyt. Biochem. 162, 24–32 (1987).
Gut, J., Catin, T., Dayer, P., Kronbach, T., Zanger, U. & Meyer, U. A. J. biol. Chem. 261, 11734–11743 (1986).
Distlerath, L. M. et al. J. biol. Chem. 260, 9057–9067 (1985).
Young, R. A. & Davis, R. W. Proc. natn. Acad. Sri U.S.A. 80, 1194–1198 (1983).
Watson, C. J. & Jackson, J. F. in DNA Cloning, Vol. 1 (ed. Glover, D. M.) 79–88 (IRL, McLean, 1985)
Nebert, D. W. & Gonzalez, F. J. A. Rev. Biochem. 56, 945–993 (1987).
Wong, G. G. et al. Science 228, 810–815 (1985).
Orkin, S. H. & Kazazian, H. H. Jr A. Rev. Genet. 18, 131–171 (1984).
Baer, A. N., McAllister, C. B., Wilkinson, G. R., Woosley, R. L. & Pincus, T. Arthritis Rheum. 29, 843–850 (1986).
Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J. & Hetzel, M. R. Nature 312, 169–170 (1984).
Idle, J. R. et al. Cancer Lett. 11, 331–338 (1981).
Luthman, H. & Magnusson, G. Nucleic Acids Res. 11, 1295–1308 (1983).
Chirgwin, J. M., Praybyla, A. W., MacDonald, R. J. & Rutter, W. J. Biochemistry 18, 5294–5299 (1979).
Lehrach, H., Diamond, D., Wozney, J. M. & Boedtker, H. Biochemistry 16, 4743–4751 (1977).
Church, G. M. & Gilbert, W. Proc. natn. Acad. Sci. U.S.A. 81, 1991–1995 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gonzalez, F., Skodat, R., Kimura, S. et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331, 442–446 (1988). https://doi.org/10.1038/331442a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/331442a0
- Springer Nature Limited
This article is cited by
-
Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling
Human Genomics (2023)
-
Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists
The Pharmacogenomics Journal (2021)
-
Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study
Malaria Journal (2018)
-
Identification of a less toxic vinca alkaloid derivative for use as a chemotherapeutic agent, based on in silico structural insights and metabolic interactions with CYP3A4 and CYP3A5
Journal of Molecular Modeling (2018)
-
The CYP2D6 VCF Translator
The Pharmacogenomics Journal (2017)